Avantor, Inc. (AVTR) 

Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.

Show less

Over the last 12 months, insiders at Avantor, Inc. have bought $0 and sold $543,753 worth of Avantor, Inc. stock.

On average, over the past 5 years, insiders at Avantor, Inc. have bought $544,479 and sold $1.24B worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 15,000 shares for transaction amount of $314,250 was made by Stubblefield Michael (CEO) on 2022‑11‑16.